Greater Cannabis Company (GCAN) Interest Coverage Ratio (2017 - 2018)
Greater Cannabis Company (GCAN) recorded quarterly Interest Coverage Ratio of 13.82 in Q3 2018, down 237.39% quarter-over-quarter from 10.06 in Q2 2018, and down 126.41% on a YoY basis from 52.33 in Q3 2017.
Greater Cannabis Company (GCAN) Interest Coverage Ratio (2017 - 2018) Analysis & Trends
Greater Cannabis Company's Interest Coverage Ratio history runs 2 years deep, the most recent figure standing at 13.82 for Q3 2018.
- In Q3 2018, Interest Coverage Ratio fell 126.41% year-over-year to 13.82; the TTM figure through Jun 2019 stood at 36.44 (down 209.18% YoY), while the FY2017 annual figure was 136.8, up 310.39% from the prior year.
- Interest Coverage Ratio was 13.82 for Q3 2018 at Greater Cannabis Company, down from 10.06 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 52.33 in Q3 2017 to a low of 706.08 in Q1 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -2.31 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.72 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Greater Cannabis Company | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -13.82 |
| Jun 30, 2018 | 10.06 |
| Mar 31, 2018 | 46.37 |
| Dec 31, 2017 | 10.82 |
| Sep 30, 2017 | 52.33 |
| Jun 30, 2017 | -30.97 |
| Mar 31, 2017 | -706.08 |